# Extended Sentinel Lymph Node Biopsy With Methylene Blue Single Tracer Post-Neoadjuvant Therapy for Node-Positive Breast Cancer

> **NCT07532096** · NA · NOT_YET_RECRUITING · sponsor: **Xijing Hospital** · enrollment: 240 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** ESLNB

## Key facts

- **NCT ID:** NCT07532096
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-25
- **Primary completion:** 2027-05-01
- **Final completion:** 2028-05-15
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07532096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07532096, "Extended Sentinel Lymph Node Biopsy With Methylene Blue Single Tracer Post-Neoadjuvant Therapy for Node-Positive Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07532096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*